Jucker, M. et al. ed.
Alzheimer: 100 Years and Beyond
Research and Perspectives in Alzheimer's Disease Series
Springer-Verlag 2006.10
544 pp. (H)
ISBN 3-540-37651-8
26,500円
Contents
1.Concerning a unique disease of the cerebral cortex/ 2.The history of Alois Alzheimer's ･rst case Auguste D/ 3.Alois Alzheimer and the beginnings of research into Alzheimer's disease/ 4.Alois Alzheimer and the myth of the pioneer/ 5.Alzheimer's Disease at mid-Century (1927 -1977)and a little more/ 6.A chapter in the development on Alzheimer's disease research/ 7.Anatomical changes underlying dementia in Alzheimer's disease/ 8.Staging of cortical neuro ･brillary inclusions of the Alzheimer's type/ 9.Of stains and brains:a brief account of how microscopic and clinical observations contributed to the understanding of Alzheimer's disease/ 10.Presenile forms of Alzheimer's disease in 2006/ 11.The cholinergic deficit in Alzheimer's disease/ 12.Acetylcholine in AD:Expectations meet reality/ 13.The Discovery of β Amyloid/ 14.Pathways to the discovery of the neuronal origin and proteolytic biogenesis of A β amyloid of Alzheimer ﾕs disease/ 15.The Amyloid Hypothesis:history and alternatives/ 16.Segregation of a missense mutation in the amyloid β -protein precursor gene with familial Alzheimer's disease/ 17.From the amyloid β protein (A4)to isolation of the first Alzheimer's disease gene:amyloid β (A4)precursor protein/ 18.Commentary on Correlative memory deficits,A β elevation, and amyloid plaques in transgenic mice/ 19.Vision for the future.Alzheimer's disease:pathogenesis,models and experimental therapeutics/ 20.Amyloid precursor protein,Alzheimer's disease,and Down's syndrome/ 21.Catabolism of amyloid β peptide and pathogenesis of sporadic Alzheimer's disease:towards understanding the underlying mechanisms/ 22.Synaptic activity,amyloid-β and Alzheimer's disease/ 23.Molecular pathogenesis of Alzheimer's disease in human peripheral cells/ 24.The neuronal origin hypothesis of cerebral amyloid angiopathy/ 25.A neuropathologist and Alzheimer genetics/ 26.Genetics,molecular biology,and animal modeling of Alzheimer's disease/ 27.The genetic Alzheimer-frontotemporal dementia spectrum/ 28.Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage,Dutch type.The role of amyloid in dementia and stroke/ 29.Physiological generation of Amyloid β -peptide and its Consequences for Alzheimer's Disease Research/ 30.Activation of α -secretase as an approach for treatment of Alzheimer's disease/ 31.Challenges to the enigma of γ -secretase and to Alzheimer's disease/ 32.Tar g e t i ng γ -Secretase for Alzheimer's Disease/ 33.The Presenilin/gamma-secretase complex and its potential as a drug target in Alzheimer's Disease/ 34.Identification of β -secretase/ 35.Apolipoprotein E and Alzheimer's disease:A brief retrospective/ 36.Apolipoprotein E4:From synaptic remodeling to genetic risk factor in both familial and sporadic Alzheimer's disease/ 37.The Alzheimer tangle -100 years on/ 38.Immunological demonstration of tau protein in neurofibrillary tangles/ 39.Bulk isolation of neurofibrillary tangles and discoveries of tau and its abnormal hyperphosphorylation/ 40.The natural and molecular history of Alzheimer's disease/ 41.Tau focused drug discovery for Alzheimer's disease and related Neurodegenerative Tauopathies/ 42.Ubiquitin is a component of paired helicalfilaments in Alzheimer 's disease/ 43.In ･uenceoftauonneuronaltraf ･cmechanisms/ 44.The Search for structure of tau and paired helicalfilaments/ 45.The Changing landscape of Alzheimer 's disease/ 46.Molecular and cellular pathways towards and away from Alzheimer's disease/ 47.Paquid:an integrated,multidisciplinary,population-based approach to normal and pathological cerebral aging/ 48.Hippocampal imaging in the early diagnosis of AD,1988 to 2006/ 49.Detecting Early-Stage Alzheimer's Disease in MCI and PreMCI/ 50.Imaging the pathology of Alzheimer's disease/ 51.How do we test drugs?/ 52.In ･ammation and the lesions of Alzheimer's diseas/ 53.A β immunotherapy prevents and Reverses Alzheimer's disease neuropathology/ 54.Immunotherapy of Alzheimer's disease/ 55.Magic bullets,shotguns or cocktails to treat or prevent Alzheimer's disease?/ 56.The seventh age of man:Solving senility/ 57.Fondation Ipsen and Alzheimer's disease:a 20-year relationship/ 58.Alzheimer Research Forum/ 59.The Potamkin prize for research in Pick ﾕs,Alzheimer's and related diseases/ References/ Subject Index / *
Jankovic, J. & Tolosa, E.
Parkinson's Disease and Movement Disorders 5th ed.
Lippincott-Williams & Wilkins 2006.10
740 pp.(H)
ISBN 0-7817-7881-6
20,100円
Contents
1.Functional Organization of the Basal Ganglia/ 2.Neurophysiology of Motor Control and Movement Disorders/ 3.Neurobehavioral Disorders Associated with Basal Ganglia Lesions/ 4.Protein Mishandling: Role of the Ubiquitin Proteasome System in the Pathogenesis of Parkinson's Disease/ 5.Epidemiology of Movement Disorders/ 6.Non-Motor Symptoms in Parkinson's Disease/ 7.Etiology and Pathogenesis of Parkinson's Disease/ 8.Genetics of Parkinson's Disease/ 9.Disease-Modifying Strategies in Parkinson's Disease/ 10.Pharmacological Management of Parkinson's Disease/ 11.Experimental Therapeutics of Parkinson's Disease/ 12.Dementia Associated with Parkinson's Disease: Features and Management/ 13.Progressive Supranuclear Palsy/ 14.Multiple System Atrophy/ 15.Corticobasal Degeneration/ 16.Inherited and Sporadic Tauopathies/ 17.Secondary Parkinsonism/ 18.Huntington's Disease/ 19.Choreas, Athetosis, and Ballism/ 20.Neurodegeneration with Brain Iron Accumulation/ 21.Wilson's Disease/ 22.Neuropathology of Parkinsonian Disorders/ 23.Mitochondrial Movement Disorders/ 24.Tremors: Differential Diagnosis, Pathophysiology, and Therapy/ 25.Dystonic Disorders/ 26.Treatment of Dystonia/ 27.Tics and Tourette's Syndrome/ 28.Myoclonus and Startle Syndrome/ 29.Treatment of Myoclonus/ 30.Drug Induced Movement Disorders/ 31.Restless Leg Syndrome/ 32.Hereditary Ataxias/ 33.Gait Disorders/ 34.Paroxysmal Dyskinesias: An Overview/ 35.Stereotopy and Catatonia/ 36.Childhood Movement Disorders/ 37.Rigidity and Spasticity/ 38.Muscle Cramps, Stiffness, and Myalgia/ 39.Assessment of Behavior in Parkinsonian Disorders/ 40.Psychogenic Movement Disorders/ 41.Neuroacanthocytosis/ 42.Prion Diseases/ 43.Functional Neuroimaging in Movement Disorders/ 44.Botulinum Toxin in Movement Disorders/ 45.Surgery for Hyperkinetic Movement Disorders/ 46.Human Embryonic Stem Cell-Based Therapy for Parkinson's Disease/ 47.Deep Brain Stimulation/ 48.Clinical Rating Scales in Movement Disorders/ * Written by an international group of renowned experts, the Fifth Edition of this premier reference provides comprehensive, current information on the genetics, pathophysiology, diagnosis, medical and surgical treatment, and b...more. *
Schwartzkroin, P.A. ed.
Epilepsy
Models, Mechanisms and Concepts
Cambridge University Press 2007.2
558 pp. (P)
ISBN 0-521-03350-0
12,700円
Contents
List of contributors; General introduction Philip A. Schwartzkroin; Part I. Chronic Models in Intact Animals - Concepts and Questions: 1. The kindling model of epilepsy J. O. McNamara, Douglas W. Bonhaus and Cheolsu Shin; 2. Focal trigger zones and pathways of propagation in seizure generation Karen Gale; 3. Genetic models of the epilepsies Phillip C. Jobe, Pravin K. Mishra, Nandor Ludvig and John W. Dailey; 4. Noradrenergic modulation of excitability: transplantation approaches to epilepsy research Olle Lindvall; 5. Sensitivity of the immature central nervous system to epileptogenic stimuli Solomon L. Mosh�, Patric K. Stanton and Ellen F. Sperber; Part II. Features of the Epileptogenic Brain: 6. Neurophysiological studies of alterations in seizure susceptibility during brain development John. W. Swann, Karen L. Smith, Robert J. Brady and Martha G. Pierson; 7. Electrophysiology and pharmacology of human neocortex and hippocampus in vitro Massimo Avoli; 8. Cell death, plasticity and epilepsy: insights provided by experimental models of hippocampal sclerosis JoAnn E. Franck; 9. Sprouting as an underlying cause of hyperexcitability in experimental models and in the human epileptic temporal lobe Thomas P. Sutula; 10. Rapidly recurring seizures and status epilepticus: ictal density as a factor in epileptogenesis Eric W. Lothman, Janet L. Stringer and Edward H. Bertram; Part III. 'Normal' Brain Mechanisms That Support Epileptiform Activities: 11. Brain slice models for the study of seizures and interictal spikes Wilkie A. Wilson and Andrew Bragdon; 12. Generation of epileptiform discharge by local circuits of neocortex Barry W. Connors and Yael Amitai; 13. Study of GABAergic inhibition and GABAA receptors in experimental epilepsy Robert K. S. Wong and Richard Miles; 14. High potassium-induced synchronous bursts and electrographic seizures Christopher J. McBain, Stephen F. Traynelis and Raymond Dingledine; 15. Anti-epileptic effects of organic calcium channel blockers in animal experiments Erwin-Josef Speckmann and J嗷g Walden; Recent advances; Index/
* Advances in epilepsy research are occurring at a rapid rate, resulting in a bewildering wealth of data. The implications of this new knowledge for future research and clinical practice can be confusing. This volume concentrates on the concepts and models of epilepsy that have been developed as a result of this research. Written by prominent researchers in the field, it describes and discusses the relevant models used to address critical questions, and reviews the most up-to-date issues. Chapters focus on the pathways and mechanisms through which seizure activity is initiated and spread, in both normal and abnormal brain tissues, and discuss the special properties of epileptogenesis in the immature brain. In a field in which rapid advances lead to constant update of empirical data, this book takes a conceptual approach to the subject and provides a solid framework within which to understand the emerging issues. *
Wyllie, E. et al.
The Treatment of Epilepsy 4th ed.
Principles and Practic てんかん治療 第4版
Lippincott-Williams & Wilkins 2005.11
1180 pp.(H)
ISBN 0-7817-4995-6
34,400円
Contents
PART I: PATHOLOGIC SUBSTRATES AND MECHANISMS OF EPILEPTOGENESIS: Section A: Cellular Aspects of Epileptogenesis/ Section B: Neurodevelopment and Pathological Substrates of Epilepsy/ Section C: Genetics and Epidemiology/ PART II: BASIC PRINCIPLES OF ELECTROENCEPHALOGRAPHY: PART III: EPILEPTIC SEIZURES AND SYNDROMES: Section A: Epileptic Seizures/ Section B: Epilepsy Syndromes: Diagnosis and Treatment/ Section C: Diagnosis and Treatment of Seizures in Special Clinical Settings/ Section D: Differential Diagnosis of Epilepsy/ PART IV: ANTIEPILEPTIC MEDICATIONS: Section A: General Principles of Antiepileptic Drug Therapy/ Section B: Specific Antiepileptic Medications and Other Therapies/ PART V: EPILEPSY SURGERY: Section A: Identification of Candidates and Presurgical Evaluation/ Section B: Epilepsy Surgery in Specific Settings/ PART VI: PSYCHOSOCIAL ASPECTS OF EPILEPSY: *
Kurlan, R.
Handbook of Secondary Dementias
二次性認知症ハンドブック
Marcel Dekker 2006.3
376 pp.
ISBN 0-8247-5433-6
29,000円
Contents
1. Dementia in Cerebrovascular Diseases/ 2. Dementia in HIV Infection and Other Sexually Transmitted Diseases/ 3. Dementia in Prion Disorders/ 4. Normal Pressure Hydrocephalus/ 5. Dementia After Traumatic Brian Injury/ 6. Dementia in Multiple Sclerosis/ 7. Dementia in Parkinson's Disease, Dementia with Lewy Bodies and Other Parkinsonian Disorders/ 8. Dementia in Huntington's Disease and Other Hyperkinetic Movement Disorders/ 9. Dementia in Neuromuscular Disorders/ 10.Dementia in Metabolic Disorders of Children and Adults/ 11. Drugs that Impair Cognition and Behavior/ 12. Depressive Pseudo-Dementia/ *
Weiner, W. J. & Lang, A.E.
Behavioral Neurology of Movement Disorders 2nd ed.
運動障害の行動神経学
Lippincott-Williams & Wilkins 2005.4
352 pp.(H)
ISBN 0-7817-5169-1
24,400円
Contents
Section 1: The Role of the Basal Ganglia: 1. Basal Ganglia: Functional Perspectives and Behavioral Domains/ 2. Behavioral Changes in Patients with Focal Lesions of the Basal Ganglia/ Section 2: Parkinson's Disease: 3. Depression in Parkinson's Disease/ 4. Anxiety Disorders in Parkinson's Disease/ 5. Disorders of Motivation, Sexual Conduct, and Sleep in Parkinson's Disease/ 6. Parkinson's Disease as a Model for Psychosocial Issues in Chronic Neurodegenerative Disease/ 7. Early Cognitive Changes and Nondementing Behavioral Abnormalities in Parkinson's Disease/ 8. Dementia in Parkinson's Disease/ 9. Behavioral Changes as Side Effects of Medication Treatment for Parkinson's Disease/ 10. Psychiatric Symptoms Following Surgery for Parkinson's Disease with an Emphasis on Subthalamic Stimulation/ Section 3: Other Akinetic Rigid Syndromes: 11. Neurodegenerative Disorders with Diffuse Cortical Lewy Bodies/ 12. Cognitive and Behavioral Changes in the Parkinson-Plus Syndromes/ 13. Behavioral Changes in Frontotemporal Dementia with Parkinsonism/ Section 4: Huntington's Disease: 14. Behavioral Symptoms Associated with Huntington's Disease/ 15. Cognitive Changes in Huntington's Disease/ 16. Psychosocial Effects of Predictive Testing for Huntington's Disease/ Section 5: Gilles de la Tourette's Syndrome: 17. Public Health Significance of Tic Disorders in Children and Adolescents/ 18. Obsessive-Compulsive Disorder in Tourette's Syndrome/ Section 6: Wilson's Disease: 19. Behavioral Abnormalities in Wilson's Disease/ Section 7: Ataxia, Essential Tremor, and Dystonia: 20. Hereditary Ataxia and Behavior/ 21. Behavioral Symptoms Associated with Essential Tremo/ 22. Behavioral and Psychiatric Manifestations in Dystonia/ Section 8: Other Movement Disorders Associated with Behavioral Changes: 23. Autoaggressive Immune-Mediated Movement Disorders/ 24. Psychopathological and Cognitive Correlates of Tardive Dyskinesia in Patients Treated with Neuroleptics/ Section 9: Psychogenic Movement Disorders: 25. Treatment Issues in Psychogenic-Neuropsychiatric Movement Disorders/ *
285-5 登録日 07.04.10
